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RESEARCH NOTE
Evaluation of a short, interactive diabetes 
self-management program by pharmacists 
for type 2 diabetes
Renu F. Singh1, Panteha Kelly2,3, Alexander Tam1,4, Jason Bronner5,6, Candis M. Morello1* and Jan D. Hirsch1
Abstract 
Objective: Numerous barriers prevent patients with type 2 diabetes (T2D) from completing a diabetes self-man-
agement program. We investigated whether patients with T2D exhibited improved clinical outcomes after attend-
ing a relatively short, interactive diabetes self-management program conducted by pharmacist diabetes educators, 
compared to a physician’s usual care.
Results: We retrospectively analyzed the data of adults with T2D who attended a diabetes self-management pro-
gram (≥ 1 group meeting or individual appointment followed by a telephone interview from a pharmacist diabetes 
educator between May 2010 and Dec. 2012; n = 513) and compared their outcomes with those of T2D patients 
who received only their physician’s usual care (n = 857). Each patient’s A1C was assessed at baseline, 3 months, and 
6 months post-intervention. The mean [SD] reduction in A1C percentage points in the T2D patients was significantly 
greater in the diabetes self-management program group compared to the physician’s usual care group at both 
3 months (− 0.8% [1.5] vs. − 0.2% [0.9], p < 0.001) and 6 months post-intervention (− 0.6% [1.3] vs. − 0.2% [1.1], 
p < 0.001). T2D patients significantly improved their glycemic control within 3–6 months of attending the diabetes 
self-management program compared to patients who only received their physician’s usual care.
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Introduction
Diabetes self-management education (DSME) programs 
educate and empower patients with diabetes to improve 
their lifestyles and self-coping skills. A 2015 national sur-
vey of diabetes educators in the United States reported 
that < 25% of patients with diabetes receive DSME 
within the first year of their diagnosis, and this value was 
unchanged from a survey conducted 3  years earlier [1, 
2]. The survey also revealed that of diabetes patients who 
do enroll in a DSME program, < 30% complete more than 
75% of the program [2], suggesting that there are barriers 
to completing DSME programs in their entirety.
In 2010, two pharmacist diabetes educators (authors RS 
and PK) initiated the diabetes self-management program 
(DSMP) within three University of California San Diego 
Health System (UCSDHS) outpatient clinics. Recogniz-
ing that patients often have limited time to attend an 
educational series, this unique program was designed 
to offer a relatively brief but highly interactive format. 
We then evaluated the effectiveness of the program by 
comparing the mean change in A1C at 3  months post-
intervention between patients with type 2 diabetes (T2D) 
who attended this DSMP and T2D patients who received 
usual care from their primary care physician (UC). Our 
secondary aims were to compare (1) the change in A1C 
between the DSMP and UC groups at 6  months post-
intervention, (2) the change in body mass index (BMI) 
between the DSMP and UC groups at 3 and 6  months 
from baseline, and (3) the percentage of patients who 
underwent an eye examination or foot examination 
within 12  months of participating in the DSMP com-
pared to the percentage in the patients who received only 
UC.
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Main text
Methods
Study design
This was a retrospective, observational, cohort study with 
a non-randomized comparator group.
Study population
Data for patients ≥ 18  years old with T2D who had 
attended at least one group meeting or one individual 
appointment in the DSMP from May 1, 2010 through 
December 31, 2012 were analyzed. UC patients’ data 
were obtained by querying the electronic medical 
records (EMR) system database for a random sample of 
patients ≥ 18  years old with the diagnosis of T2D who 
were seen by a primary care physician during the same 
time period, but who did not enroll in the DSMP.
Intervention
Adult patients with diabetes were referred to the DSMP 
for group meetings or individual appointments by their 
healthcare providers at UCSDHS, based on the patients’ 
data in their EMR. Conducted by a pharmacist diabetes 
educator, the group meetings consisted of two core ses-
sions, each 2 h in length, covering 3–4 diabetes self-man-
agement topics per session and spaced 1–2 weeks apart. 
The DSMP was conducted on weekdays, with group 
meetings and individual appointments offered during the 
day or evening. Prior to each class, the pharmacist dia-
betes educator reviewed each patient’s medical record, 
including his or her diabetes medications, glycemic con-
trol, and reason for referral. This enabled the educator 
to tailor the group class to the needs of the individual 
patients to a certain degree. All DSMP patients received 
a telephone follow-up call from a pharmacist educator 
1–2 weeks after their completion of the final group meet-
ing or individual appointment.
The diabetes pharmacist educators practiced under a 
limited collaborative practice agreement for the DSMP 
that enabled them to order diabetes testing supplies, 
refills of existing diabetes medications, pertinent labora-
tory tests, and referrals for annual eye exams.
Outcome measures
This study measured the mean change in A1C and BMI at 
baseline compared to 3 months and 6 months post inter-
vention between the DSMP and UC groups. The closest 
A1C and BMI values within 6  months prior to the date 
of the first DSMP session were used as the baseline A1C 
and BMI values. For the 3- and 6-month data, the clos-
est A1C and BMI values within 45 days of 3 or 6 months 
post-intervention were used. Additionally, we compared 
the percentage of patients who had undergone an eye 
exam or foot exam in the previous 12 months before the 
DSMP session or 12  months prior to their last primary 
care visit in the UC group, to the percentage of patients 
who received an eye or foot exam in the subsequent 
12 month post intervention period.
Data analysis
A sample size of 343 patients per group was estimated as 
sufficient to test a difference in the mean change in A1C 
between the DSMP and UC groups assuming a two-sided 
test of significance, a mean standard deviation (SD) of 
DSMP A1C of 0.7 (SD 2.1) and UC A1C of 0.3 (SD 0.9), 
90% power, and alpha = 0.05. Descriptive statistics were 
calculated for all variables. Continuous variables were 
compared by t-test, and categorical variables were com-
pared by Chi-square test.
Results
The DSMP (n = 513) and UC (n = 857) groups’ charac-
teristics at baseline are summarized in Table 1. The mean 
(SD) age was significantly lower, though not considered 
to be clinically significant, in the DSMP group compared 
to the UC group: 61.3 (11.9) years vs. 66.5 (13.5) years, 
p < 0.001.
The baseline A1C and BMI values of patients in the 
DSMP group were significantly higher compared to the 
UC group: A1C, 8.1% (1.8) vs. 7.1% (1.2), p < 0.001, and 
BMI, 32.1  kg/m2 (7.7) vs. 30.6  kg/m2 (7.4), p = 0.001, 
respectively. At baseline, a significantly larger proportion 
of patients in the UC group had undergone an eye exam 
in the past 12  months compared to the DSMP group: 
66.3% vs. 56.3%, p < 0.001. The proportion of patients who 
had undergone a foot exam in the previous 12  months 
was equal in the UC and DSMP group: 51.0% vs. 51.0%, 
p = 0.999, respectively.
Among the patients in the DSMP group, 45.8% 
attended one or two group meetings and 13.2% attended 
three or four group meetings; the remaining 41% of 
the patients were seen individually. Of the patients 
Table 1 T2D patient characteristics at baseline
T2D type 2 diabetes, DSMP diabetes self management program, UC usual care
DSMP UC p value
n 513 857
Males, n (%) 259 (50.5) 414 (48.3) 0.44
Age, mean (SD) 61.3 (11.9) 66.5 (13.4) < 0.001
A1C,  % mean (SD) 8.1 (1.8) 7.1 (1.2) < 0.001
A1C, mmol/mol, mean (SD) 65.0 (19.7) 54.0 (13.1) < 0.001
BMI, mean (SD) 32.1 (7.7) 30.6 (7.4) 0.001
Patients having had eye exams, n (%) 289 (56.3) 568 (66.3) < 0.001
Patients having had foot exams, n (%) 261 (51.0) 436 (51.0) 0.999
Page 3 of 4Singh et al. BMC Res Notes          (2018) 11:828 
who were seen individually, 77.7% had 1–2 individual 
appointments, 17.1% had three appointments, and 5% 
had 4–8 appointments. Of the DSMP-group patients, 
55.8% received 1–3 phone calls, and a minority (17.7%) 
received ≥ 4 calls. On average, the total amount of con-
tact time per patient (individual appointments plus group 
meetings) was 4 h.
At 3  months post-intervention, patients in the DSMP 
group had a significantly greater mean change in A1C; 
i.e., a mean (SD) − 0.8% (1.5) reduction compared to that 
of the UC group at − 0.2% (0.9), p < 0.001. (Table 2) The 
mean decrease in A1C at 6 months post-intervention was 
also significantly greater in the DSMP group at −  0.6% 
(1.3) compared to the UC group at − 0.2% (1.1), p < 0.001. 
There was no significant difference in the mean BMI 
change between the patients in the DSMP versus UC 
groups at 3 months: − 0.2 (1.4) and − 0.1 (1.4), respec-
tively, p = 0.076 and at 6 months: − 0.2 (1.8) versus − 0.1 
(1.9), respectively, p = 0.172 (Table 3).
Of the patients who had not undergone an eye exam 
in the previous 12 months (224 in DSMP group and 289 
in UC group), the percentage undergoing an eye exam in 
the subsequent 12 months was not significantly different 
between groups [98 (44%) DSMP group vs. 136 (47%) in 
UC group, p = 0.456]. Similarly, of the patients who had 
not undergone a foot exam in the previous 12  months 
(252 in DSMP group and 421 in UC group), the percent-
age undergoing a foot exam in the subsequent 12 months 
was not significantly different between groups [72 (29%) 
DSMP group vs. 139 (33%) in UC group, p = 0.229].
Discussion
Overall, at 3  months after the intervention, patients 
who participated in the short-term model of the DSMP 
achieved a significantly greater reduction in A1C com-
pared to patients who received only UC. Moreover, the 
A1C values of the DSMP group continued to be signifi-
cantly lower than those of the UC patients at 6 months 
post-intervention. Patients in the DSMP group had 
higher baseline A1C values than the UC group, as would 
be expected, since physicians would refer diabetes 
patients with poorer glycemic control to a DSMP. How-
ever, the magnitude of the A1C reduction in the patients 
who participated in the DSMP (−  0.8 at 3  months and 
− 0.6 at 6 months) compares favorably to a meta-analy-
sis and a review in which the reported mean decrease in 
A1C in T2D patients who attended DSME programs was 
0.74–0.76 at follow-up [3, 4].
A 2015 meta-analysis of 132 randomized, controlled 
trials of ≥ 4-week DSME programs published between 
1993 and 2015 concluded that DSME behavioral pro-
grams that provide ≤ 10  h of education offer little ben-
efit for A1C reduction [5]. However, our present findings 
demonstrated that 2–4  h of a concentrated, interactive 
DSME program over a period of 1–2  weeks with a tel-
ephone follow-up from a pharmacist diabetes educator 
within 1–2 weeks of the final group meeting or individ-
ual appointment significantly improved glycemic control 
within a short term in patients with T2D. While patients 
have provided many diverse and complex reasons for 
not attending DSME programs, one significant reason is 
logistical, including the length of a program [6]. The rela-
tively short DSMP described herein enables pharmacist 
educators to cover several topics at the first group meet-
ing or individual appointment and address the most con-
cerning questions that patients have at their first visit. 
Moreover, the follow-up telephone calls enabled our 
pharmacist educators to address the individual needs of 
each patient and provide support after initially establish-
ing a relationship with patients.
Improving glycemic control has been reported to 
cause weight gain, particularly with upward insulin titra-
tion [7, 8]. We observed no significant change in the 
patients’ BMI at 3 or 6  months following intervention 
in either the DSMP or UC group. While the DSMP dis-
cussed nutrition, physical activity and behavioral strate-
gies to lose weight, weight loss was not observed in the 
patients; however, their BMI values did not increase. 
We also observed no significant difference between the 
percentage of patients who completed the DSMP and 
underwent eye and foot examinations within 12 months 
of their first group meeting or individual appointment 
compared to the UC group. The U.S. Centers for Disease 
Control and Prevention stated that nationwide in 2012, 
64.9% of patients with diabetes had reported undergoing 
a dilated eye exam and 71.2% reported having completed 
an annual foot exam in the previous 12 months [9]. Both 
Table 2 T2D A1C change 3 and 6 months post-intervention
T2D type 2 diabetes, DSMP diabetes self management program, UC usual care
A1C % change DSMP UC p
n Mean (SD) n Mean (SD)
3 months 295 − 0.8 (1.5) 857 − 0.2 (0.9) < 0.001
6 months 234 − 0.6 (1.3) 475 − 0.2 (1.1) < 0.001
Table 3 T2D BMI change 3 and 6 months post-intervention
T2D type 2 diabetes, DSMP diabetes self management program, UC usual care
BMI (kg/m2) change DSMP UC p
n Mean (SD) n Mean (SD)
3 months 382 − 0.2 (1.4) 857 − 0.1 (1.4) 0.076
6 months 311 − 0.2 (1.8) 713 − 0.1 (1.9) 0.172
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the present DSMP and UC groups had low foot examina-
tion rates.
Limitations
The limitations of this study include the retrospective 
data collection at a single site and use of a non-rand-
omized comparator group. Medical examinations (such 
as eye exams) and lab data that were not performed at 
a UCSDHS clinic were not available for review. In addi-
tion, the ability of the pharmacist educators to order dia-
betes testing supplies and refills of diabetes medications 
may have contributed to the favorable glycemic response 
observed in this study, since this ability likely facilitated 
self-monitored blood glucose testing and diabetes medi-
cation adherence. Another limitation is that although 
the pharmacist educators provided medication recom-
mendations in the patients’ EMR, we did not measure the 
percentage of recommendations that were subsequently 
accepted by referring providers. Compared to the DSMP 
patients, more of the UC patients at baseline had under-
gone an eye exam in the previous 12 months, suggesting 
that patients who were less likely to see an eye specialist 
and/or less likely to adhere to an eye specialist’s regimen 
were being referred to the DSMP. Lastly, the effects on 
the patients’ A1C values beyond 6 months after comple-
tion of the DSMP were not evaluated in this study.
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